Ftse Mib
34.683,85
-0,43%
DAX
18.557,27
-0,48%
S&P 500
5.360,13
0,13%
NASDAQ
17.198,78
0,15%
Bitcoin
69.632,68
-1,60%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pear Therapeutics Inc (PEAR) Pear Therapeutics Inc (PEAR) Notizie

PEAR

Pear Therapeutics (PEAR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PEAR
DataOraFonteTitoloSimboloCompagnia
02/05/202319:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PEARPear Therapeutics Inc
12/04/202322:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PEARPear Therapeutics Inc
10/04/202322:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PEARPear Therapeutics Inc
07/04/202317:30Business WirePear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales ProcessNASDAQ:PEARPear Therapeutics Inc
03/04/202322:05GlobeNewswire Inc.Sight Sciences Appoints Ali Bauerlein as Chief Financial OfficerNASDAQ:PEARPear Therapeutics Inc
31/03/202322:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PEARPear Therapeutics Inc
17/03/202314:15Business WirePear Therapeutics Announces Process Exploring Strategic AlternativesNASDAQ:PEARPear Therapeutics Inc
27/02/202314:00Business WirePear Therapeutics to Participate in 43rd Annual Cowen Healthcare ConferenceNASDAQ:PEARPear Therapeutics Inc
09/02/202322:43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PEARPear Therapeutics Inc
02/02/202314:00Business WirePear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:PEARPear Therapeutics Inc
26/01/202314:00Business WirePear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use DisordersNASDAQ:PEARPear Therapeutics Inc
24/01/202322:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PEARPear Therapeutics Inc
18/01/202314:00Business WirePear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug ListNASDAQ:PEARPear Therapeutics Inc
17/01/202314:00Business WirePear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat SeriesNASDAQ:PEARPear Therapeutics Inc
12/01/202314:00Business WireCalifornia Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives ProgramNASDAQ:PEARPear Therapeutics Inc
10/01/202322:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PEARPear Therapeutics Inc
10/01/202314:00Business WirePear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital TherapeuticsNASDAQ:PEARPear Therapeutics Inc
04/01/202322:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PEARPear Therapeutics Inc
04/01/202314:00Business WirePear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and StatesNASDAQ:PEARPear Therapeutics Inc
04/01/202312:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PEARPear Therapeutics Inc
03/01/202313:38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PEARPear Therapeutics Inc
15/12/202214:00Business WirePear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAPNASDAQ:PEARPear Therapeutics Inc
21/11/202214:00Business WirePear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx ConferenceNASDAQ:PEARPear Therapeutics Inc
15/11/202201:45TipRanksPear Therapeutics (PEAR) Receives a Buy from BTIGNASDAQ:PEARPear Therapeutics Inc
14/11/202223:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PEARPear Therapeutics Inc
14/11/202222:02Business WirePear Therapeutics Reports Third Quarter 2022 ResultsNASDAQ:PEARPear Therapeutics Inc
10/11/202214:00Business WirePear Therapeutics to Participate in the BTIG Digital Health ForumNASDAQ:PEARPear Therapeutics Inc
07/11/202214:00Business WirePear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR EuropeNASDAQ:PEARPear Therapeutics Inc
03/11/202213:00Business WireState of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction CrisisNASDAQ:PEARPear Therapeutics Inc
01/11/202221:02Business WirePear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare ConferenceNASDAQ:PEARPear Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PEAR

La tua Cronologia

USOTC
CRUCF
Colibri Resource (PK)
UNSW
NEXTETH
NEXT
TG
DBAN
Deutsche Beteiligungs
BIT
UC1TKW
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network